Featured Presentation: EPA vs. DHA
10:30am – 11:00am / Thursday February 17th
This session will be live-streamed.
There have been questions for years on the benefits of EPA versus DHA and which health outcome or condition might be better suited for one fatty acid versus the other. The success of high EPA pharmaceutical products have challenged supply chain dynamics and added a sense of urgency to the conversation. Now that GOED has finished the data extraction for our clinical study database, we can answer the question, “What does the science say?” and answer the EPA versus DHA question once and for all.